Rapid Communication|Articles in Press

Prioritizing harm reduction services to reduce the burden of substance use: A joint position statement of the International Society of Psychiatric Mental Health Nurses (ISPN) and the International Nurses Society on Addictions (IntNSA)-USA Chapter

      The International Society of Psychiatric Mental Health Nurses (ISPN) and the International Nurses Society on Addictions (IntNSA)-USA Chapter jointly recognize the need to promote harm reduction services to reduce the burden of substance use across the world. ISPN's mission is “to support advanced-practice psychiatric-mental health nurses in promoting mental health care, literacy, and policy worldwide.” IntNSA's mission is “to advance excellence in nursing care for the prevention and treatment of addictions for diverse populations across all practice settings through advocacy, collaboration, education, research, and policy development.” Together, ISPN and IntNSA-USA seek to make recommendations to improve the quality of and access to harm reduction services for individuals with substance use-related problems.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Psychiatric Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Abouk R.
        • Pacula R.L.
        • Powell D.
        Association between state laws facilitating pharmacy distribution of naloxone and risk of fatal overdose.
        JAMA Internal Medicine. 2019; 179: 805-811
        • Ahmad F.B.
        • Cisewski J.A.
        • Rossen L.M.
        • Sutton P.
        Provisional drug overdose death counts.
        (Retrieved on October 6, 2022, from)
        • Ashford R.D.
        • Curtis B.
        • Brown A.M.
        Peer-delivered harm reduction and recovery support services: Initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
        Harm Reduction Journal. 2018; 15: 1-9
        • Azagba S.
        • Shan L.
        • Qeadan F.
        • Wolfson M.
        Unemployment rate, opioids misuse and other substance abuse: Quasi-experimental evidence from treatment admissions data.
        BMC Psychiatry. 2021; 21: 1-9
        • Borges M.
        • Gouveia M.
        • Fiorentino F.
        • Jesus G.
        • Cary M.
        • Guerreiro J.P.
        • Costa S.
        • Carneiro A.V.
        Costs and consequences of the Portuguese needle-exchange program in community pharmacies.
        Canadian Pharmacists Journal/Revue des Pharmaciens du Canada. 2020; 153: 170-178
        • Castelpietra G.
        • Knudsen A.K.S.
        • Agardh E.E.
        • Armocida B.
        • Beghi M.
        • Iburg K.M.
        • Monasta L.
        The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the global burden of disease study 2019.
        The Lancet Regional Health-Europe. 2022; 16100341
        • Centers for Disease Control and Prevention
        Sterile needle exchange frequently asked questions.
        (Retrieved on October 10, 2022, from)
        • Cotter T.G.
        • Stier M.W.
        • Aronsohn A.
        PrO: Needle exchange programs should be instituted to reduce hepatitis C virus transmission.
        Clinical Liver Disease. 2018; 12: 170
        • John W.S.
        • Zhu H.
        • Mannelli P.
        • Schwartz R.P.
        • Subramaniam G.A.
        • Wu L.T.
        Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients.
        Drug and Alcohol Dependence. 2018; 187: 79-87
        • Jones C.M.
        • Noonan R.K.
        • Compton W.M.
        Prevalence and correlates of ever having a substance use problem and substance use recovery status among adults in the United States, 2018.
        Drug and Alcohol Dependence. 2020; 214108169
        • Karamouzian M.
        • Dohoo C.
        • Forsting S.
        • McNeil R.
        • Kerr T.
        • Lysyshyn M.
        Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada.
        Harm Reduction Journal. 2018; 15
        • Krieger M.S.
        • Yedinak J.L.
        • Buxton J.A.
        • Lysyshyn M.
        • Bernstein E.
        • Rich J.D.
        • Green T.C.
        • Hadland S.E.
        • Marshall B.D.
        High willingness to use rapid fentanyl test strips among young adults who use drugs.
        Harm Reduction Journal. 2018; 15
        • Lambdin B.H.
        • Bluthenthal R.N.
        • Wenger L.D.
        • Wheeler E.
        • Garner B.
        • Lakosky P.
        • Kral A.H.
        Overdose education and naloxone distribution within syringe service programs—United States, 2019.
        Morbidity and Mortality Weekly Report. 2020; 69: 1117
        • McVicar D.
        • Moschion J.
        • van Ours J.C.
        Early illicit drug use and the age of onset of homelessness.
        Journal of the Royal Statistical Society: Series A (Statistics in Society). 2019; 182: 345-372
        • Mir M.U.
        • Akhtar F.
        • Zhang M.
        • Thomas N.J.
        • Shao H.
        A meta-analysis of the association between needle exchange programs and HIV seroconversion among injection drug users.
        Cureus. 2018; 10
        • Mistler C.B.
        • Rosen A.O.
        • Eger W.
        • Copenhaver M.M.
        • Shrestha R.
        Fentanyl test strip use and overdose history among individuals on medication for opioid use disorder.
        Austin Journal of Public Health and Epidemiology. 2021; 8: 1117
        • National Institute on Drug Abuse
        Drugs, brains, and behavior: The science of addiction – Addiction and Health.
        (Retrieved on October 6, 2022, from)
        • Naumann R.B.
        • Durrance C.P.
        • Ranapurwala S.I.
        • Austin A.E.
        • Proescholdbell S.
        • Childs R.
        • Shanahan M.E.
        Impact of a community-based naloxone distribution program on opioid overdose death rates.
        Drug and Alcohol Dependence. 2019; 204: 107536
        • O’Donnell J.K.
        • Halpin J.
        • Mattson C.L.
        • Goldberger B.A.
        • Gladden R.M.
        Deaths involving fentanyl, fentanyl analogs, and U-47700—10 states, July–December 2016.
        Morbidity and Mortality Weekly Report. 2017; 66: 1197
        • O’Keefe D.
        • Wilkinson A.
        • Aitken C.
        • Dietze P.
        Geo-spatial analysis of individual level needle and syringe coverage in Melbourne, Australia.
        PLOS One. 2018; 13e0209280
        • Park J.N.
        • Tomko C.
        • Silberzahn B.E.
        • Haney K.
        • Marshall B.D.
        • Sherman S.G.
        A fentanyl test strip intervention to reduce overdose risk among female sex workers who use drugs in Baltimore: Results from a pilot study.
        Addictive Behaviors. 2020; 110106529
        • Peacock A.
        • Leung J.
        • Larney S.
        • Colledge S.
        • Hickman M.
        • Rehm J.
        • Degenhardt L.
        Global statistics on alcohol, tobacco and illicit drug use: 2017 status report.
        Addiction. 2018; 113: 1905-1926
        • Peiper N.C.
        • Clarke S.D.
        • Vincent L.B.
        • Ciccarone D.
        • Kral A.H.
        • Zibbell J.E.
        Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the southeastern United States.
        International Journal of Drug Policy. 2019; 63: 122-128
        • Recovery Centers of America
        Economic cost of substance abuse disorder in the United States, 2019.
        (Retrieved on October 6, 2022 from)
        • Rees D.I.
        • Sabia J.J.
        • Argys L.M.
        • Dave D.
        • Latshaw J.
        With a little help from my friends: The effects of good samaritan and naloxone access laws on opioid-related deaths.
        The Journal of Law and Economics. 2019; 62: 1-27
        • Rehm J.
        • Manthey J.
        • Shield K.D.
        • Ferreira-Borges C.
        Trends in substance use and in the attributable burden of disease and mortality in the WHO european region, 2010–16.
        European Journal of Public Health. 2019; 29: 723-728
        • Smart R.
        • Pardo B.
        • Davis C.S.
        Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.
        Addiction. 2021; 116: 6-17
        • Substance Abuse and Mental Health Services Administration
        Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health.
        (Retrieved on October 6, 2022, from)
        • Substance Abuse and Mental Health Services Administration
        Harm reduction.
        (Retrieved on October 6, 2022, from)
        • Sweeney S.
        • Ward Z.
        • Platt L.
        • Guinness L.
        • Hickman M.
        • Hope V.
        • Maher L.
        • Iversen J.
        • Hutchinson S.J.
        • Smith J.
        • Ayres R.
        • Hainey I.
        • Vickerman P.
        Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs.
        Addiction. 2019; 114: 560-570
        • Townsend T.
        • Blostein F.
        • Doan T.
        • Madson-Olson S.
        • Galecki P.
        • Hutton D.W.
        Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States.
        International Journal of Drug Policy. 2020; 75102536
        • Tupper K.W.
        • McCrae K.
        • Garber I.
        • Lysyshyn M.
        • Wood E.
        Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
        Drug and Alcohol Dependence. 2018; 190: 242-245
        • van de Baan F.C.
        • Montanari L.
        • Royuela L.
        • Lemmens P.H.
        Prevalence of illicit drug use before imprisonment in Europe: Results from a comprehensive literature review.
        Drugs: Education, Prevention and Policy. 2022; 29: 1-12
        • Värmå M.
        • Strömdahl S.
        • Ekström A.M.
        • Kåberg M.
        • Karlsson N.
        • Dahlborn H.
        • Hammarberg A.
        A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs.
        Harm Reduction Journal. 2020; 17: 1-10
        • Vidourek R.A.
        • King K.A.
        • Yockey R.A.
        • Becker K.J.
        • Merianos A.L.
        Straight to the point: A systematic review of needle exchange programs in the United States.
        Journal of Behavioral Health. 2019; : 10
        • Vilsaint C.L.
        • NeMoyer A.
        • Fillbrunn M.
        • Sadikova E.
        • Kessler R.C.
        • Sampson N.A.
        • Alegría M.
        Racial/ethnic differences in 12-month prevalence and persistence of mood, anxiety, and substance use disorders: Variation by nativity and socioeconomic status.
        Comprehensive Psychiatry. 2019; 89: 52-60
        • Whiteman A.
        • Burnett J.
        • Handanagic S.
        • Wejnert C.
        • Broz D.
        • NHBS Study Group
        Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment-17 US cities, 2015.
        International Journal of Drug Policy. 2020; 85102923
        • Wilson N.
        • Kariisa M.
        • Seth P.
        • Smith IV, H.
        • Davis N.L.
        Drug and opioid-involved overdose deaths—United States, 2017–2018.
        Morbidity and Mortality Weekly Report. 2020; 69: 290
        • Xu J.
        • Davis C.S.
        • Cruz M.
        • Lurie P.
        State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies.
        Drug and Alcohol Dependence. 2018; 189: 37-41